Lupus as a model of neuroimmune interactions

NeuroImmune Biology

Volumn 1, Issue C, 2001, Pages 379-386

  Denburg, Judah A ^a   Sakic, Boris ^a   Szechtman, Henry ^a   Denburg, Susan D ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957782171     PISSN: 15677443     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-7443(01)80034-X     Document Type: Article

References (36)

1. Denburg J.A., Denburg S.D., Carbotte R.M., Sakic B., and Szechtman H. Nervous system lupus: pathogenesis and rationale for therapy. Scand. J Rheumatol 24 (1995) 263-273
2. Carbotte R.M., Denburg S.D., and Denburg J.A. Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis 174 (1986) 357-364
3. Denburg S.D., and Denburg J.A. Cognitive dysfunction in systemic lupus erythematosus. In: Lahita R.G. (Ed). Systemic Lupus Erythematosus. 3 ed (1999), Academic Press, San Diego 611-629
4. Denburg S.D., Carbotte R.M., and Denburg J.A. Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. Arthritis Rheum 37 (1994) 1311-1320
5. Denburg S.D., Behmann S.A., Carbotte R.M., and Denburg J.A. Lymphocyte antigens in neuropsychiatric systemic lupus erythematosus: Relationship of lymphocyte antibody specificities to clinical disease. Arthritis Rheum 37 (1994) 369-375
6. Denburg S.D., Carbotte R.M., Long A.A., and Denburg J.A. Neuropsychological correlates of serum lymphocytotoxic antibodies in systemic lupus erythematosus. Brain Behav Immun 2 (1988) 222-234
7. Denburg S.D., Carbotte R.M., Ginsberg J.S., and Denburg J.A. The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. J Int Neuropsychol Soc 3 (1997) 377-386
8. Sakic B., Szechtman H., Braciak T., Richards C., Gauldie J., and Denburg J.A. Reduced preference for sucrose in autoimmune mice: a possible role of interleukin-6. Brain Res Bull 44 (1997) 155-165
9. Hay E.M., Huddy A., Black D., Mbaya P., Tomenson B., Bernstein R.M., Holt P.J.L., and Creed F. A prospective study of psychiatric disorder and cognitive function in systemic lupus erythematosus. Ann Rheum Dis 53 (1994) 298-303
10. Hanly J.G., Fisk J.D., Sherwood G., and Eastwood B. Clinical course of cognitive dysfunction in systemic lupus erythematosus. J Rheumatol 21 (1994) 1825-1831
11. in press (abstract). Boulos P., Denburg J.A., Goldsmith C.H., Stewart K., and Denburg S.D. The predictive value of neurocognitive deficits for neuropsychiatric events in antiphospholipid antibody positive lupus patients. J Rheumatol (2000)
12. Bonfa E., Golombek S.J., Kaufman L.D., Skelly S., Weissbach H., Brot N., and Elkon K.B. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 317 (1987) 265-271
13. Denburg S.D., Carbotte R.M., and Denburg J.A. Cognition and mood in SLE: evaluation and pathogenesis. Ann NY Acad Sci 823 (1997) 44-59
14. Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A., and Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356 (1992) 314-317
15. Sakic B., Szechtman H., and Denburg J.A. Neurobehavioral alterations in autoimmune mice. NeuroSci Biobehav Rev 21 (1997) 327-340
16. Farrell M., Sakic B., Szechtman H., and Denburg J.A. Effect of cyclophosphamide on leukocytic infiltration in the brain of MRL/lpr mice. Lupus 6 (1997) 268-274
17. Ellis S.G., and Verity M.A. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955-1977. Semin Arthritis Rheum 8 (1979) 212-221
18. Sakic B., Szechtman H., Keffer M., Talangbayan H., Stead R., and Denburg J.A. A behavioral profile of autoimmune lupus-prone MRL mice. Brain Behav Immun 6 (1992) 265-285
19. Carbotte R.M., Denburg S.D., and Denburg J.A. Cognitive deficit associated with rheumatic diseases: neuropsychological perspectives. Arthritis Rheum 38 (1995) 1363-1374
20. Sakic B., Szechtman H., Talangbayan H., Denburg S., Carbotte R., and Denburg J.A. Behavior and immune status of MRL mice in the postweaning period. Brain Behav Immun 8 (1994) 1-13
21. Millward J.M. T-lymphocyte infiltration into brains of MRL-lpr mice: a model for systemic lupus erythematosus. Biology Senior Thesis (1999), McMaster University
22. Sakic B., Denburg J.A., Denburg S.D., and Szechtman H. Blunted sensitivity to sucrose in autoimmune MRL-lpr mice: a curve-shift study. Brain Res Bull 41 (1996) 305-311
23. Papp M., Willner P., and Muscat R. An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology 104 (1991) 255-259
24. Monleon S., D'Aquila P., Parra A., Simon V.M., Brain P.F., and Willner P. Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine. Psychopharmacology 117 (1995) 453-457
25. McEwen B.S., Gould E.A., and Sakai R.R. The vulnerability of the hippocampus to protective and destructive effects of glucocorticoids in relation to stress. Br J Psychiatry Suppl (1992) 18-23
26. Frei K., Leist T.P., Meager A., Gallo P., Leppert D., Zinkernagel R.M., and Fountana A. Production of B cell stimulatory factor-2 and interferon τ in the central nervous system during viral meningitis and encephalitis: evaluation in a murine model infection and in patients. J Exp Med 168 (1988) 449-453
27. Hirohata S., and Miyamoto T. Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum 33 (1990) 644-649
28. Shiozawa S., Kuroki Y., Kim M., Hirohata S., and Ogino T. Interferon-alpha in lupus psychosis. Arthritis Rheum 35 (1992) 417-422
29. Morris J.G., Tang L.P., Sparacio S.M., and Benveniste E.N. Signal transduction pathways mediating astrocyte IL-6 induction by IL-1 beta and tumor necrosis factor-alpha. J Immunol 152 (1994) 841-850
30. (in press). Sakic B., Szechtman H., Gauldie J., and Denburg J.A. Behavioral effects of infection with IL-6 adenovector. Brain Behav Immun (2000)
31. Campbell I.L., Abraham C.A., Masliah E., Kemper P., Inglis J.D., Oldstone M.B., and Mucke L. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci USA 90 (1993) 10061-10065
32. Ringheim G.E., Burgher K.L., and Heroux J.A. Interleukin-6 mRNA expression by cortical neurons in culture: evidence for neuronal sources of interleukin-6 production in the brain. J Neuroimmunol 63 (1995) 113-123
33. Spangelo B.L., MacLeod R.M., and Isakson P.C. Production of interleukin-6 by anterior pituitary cells in vitro. Endocrinology 126 (1990) 582-586
34. Lyson K., and McCann S.M. Alpha-melanocyte-stimulating hormone abolishes IL-1- and IL-6- induced corticotropin-releasing factor release from the hypothalamus in vitro. Neuroendocrinology 58 (1993) 191-195
35. Hagiwara E., Gourley M.F., Lee S., and Klinman D.M. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: Interferon-gamma-secretingcells in the peripheral blood. Arthritis Rheum 39 (1996) 379-385
36. Sluzewska A., Rybakowski J.K., Laciak M., Mackiewicz A., Sobieska M., and Wiktorowicz K. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann NY Acad Sci 762 (1995) 474-476